Kvika banki hf.
8.3.2021 16:26:29 CET | Globenewswire | Press release
A shareholders’ meeting of Kvika banki hf., Reg. No. 540502-2930, will be held on Tuesday, 30 March 2021, at 4:00 pm at Hilton Reykjavík Nordica, Suðurlandsbraut 2, 108 Reykjavík.
The Agenda for the meeting is as follows:
- Motion of the Board of Directors for the merger of Kvika banki hf., TM hf. and Lykill fjármögnun hf.
- Motion of the Board of Directors to amend the company's Articles of Association in connection with the merger, i.e. concerning an increase in share capital.
- Discussion and other business legally presented.
The meeting will be held in Icelandic. Meeting documents are available on the company's website in both Icelandic and English, with the exception of the company's annual financial statements, which are only available in English. Meeting documents are available on the website https://www.kvika.is/en/investor-relations/shareholders-meeting, see also in Icelandic here: https://www.kvika.is/fjarfestaupplysingar/hluthafafundir/ and at the company's office at Katrínartún 2, 105 Reykjavík.
For further information, please find attached Announcement of Shareholders’ Meeting.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
King Faisal Specialist Hospital & Research Centre13.3.2026 22:15:53 CET | Press release
KFSH Leads Globally in Paired Kidney Transplants Performed at a Single Center in 2025
SCOR13.3.2026 18:59:39 CET | Press release
SCOR SE announces the availability of its 2025 Universal Registration Document
Novartis Pharma AG13.3.2026 18:35:19 CET | Press release
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
Luotea Oyj13.3.2026 18:30:00 CET | Press release
The Board of Directors of Luotea Oyj decided on updates to the company's share-based incentive plan for 2023-2027 and on the launch of a new share-based incentive plan for the years 2026-2030
Ilkka Oyj13.3.2026 18:00:00 CET | Press release
Ilkka Oyj: Acquisition of own shares on 13 March 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
